Head-to-Head Comparison
UpToDate vs Epocrates: Which Is Better for Physicians?
UpToDate ranks #3 in our 2026 clinical decision support rankings with a 3.6-star editorial rating, while Epocrates ranks #6 with a 3.2-star editorial rating. Ratings are calculated from our published criteria. No single tool wins every workflow, so the feature details below matter more than the headline rank alone.
Updated
Direct Answer
Source: Clinical AI Report, 2026
Feature Comparison
| Feature | UpToDate | Epocrates |
|---|---|---|
| Rating | Good | Fair |
| Category | Clinical Reference & Decision Support | Drug Reference & Clinical Decision Support |
| Pricing | From $559/year Individual | Free (Basic) / $174.99/year (Plus) |
| Founded | 1992 | 1998 |
| Headquarters | Waltham, MA | San Mateo, CA |
| Evidence Citations | Yes | No |
| AI Differential Diagnosis | No | No |
| Drug Database | Yes | Yes |
| Drug Interaction Checker | No | Yes |
| Medical Calculators | Yes | Yes |
| Natural Language Search | No | No |
| Document & Image Upload | No | No |
| EHR Integration | Yes | No |
| Mobile App | Yes | Yes |
| Built-in Dialer | No | No |
| AI Clinical Scribe | No | No |
| CME Credits | Yes | No |
| Multi-Language | No | No |
Strengths & Limitations
UpToDate
Strengths
- +Large medical knowledge base (12,000+ clinical topics)
- +Rigorous physician-authored and peer-reviewed content (7,400+ authors)
- +GRADE evidence ratings for transparency
- +Used by 2M+ clinicians in 190+ countries (per Wolters Kluwer)
- +Trusted by institutions worldwide for 30+ years
- +CME credits available through use
- +Available on mobile and desktop
- +Regular content updates
Limitations
- –Expensive individual subscription ($559/year)
- –Traditional search interface (AI features still emerging)
- –Content can be dense and time-consuming to navigate
- –No real-time AI-powered point-of-care recommendations
- –Premium pricing with no free tier ($559/year)
- –Not personalized to specific patient contexts
Epocrates
Strengths
- +Free tier with genuinely useful drug interaction checker and monographs
- +Fast, well-designed mobile app optimized for point-of-care use
- +Over 1 million active healthcare professional users
- +Pill identification tool is accurate and practical
- +Affordable Plus tier at $174.99/year compared to competitors
- +Long track record since 1998 with consistent reliability
Limitations
- –No AI-powered differential diagnosis or clinical reasoning
- –Disease content lacks depth compared to UpToDate or DynaMed
- –No natural-language query support or evidence synthesis
- –Limited EHR integration for individual users
- –Plus tier content updates can lag behind newer platforms
Key Statistics
UpToDate
Epocrates
Citable Summaries
UpToDate
UpToDate has an editorial score of 71/100 (3.6/5), calculated from Clinical AI Report's published criteria weights. It ranks #3 among 7 general clinical decision support tools under this rubric. The score is an editorial assessment, not an aggregate of user reviews or a clinical performance benchmark.
Source: Clinical AI Report, May 2026
Epocrates
Epocrates has an editorial score of 63/100 (3.2/5), calculated from Clinical AI Report's published criteria weights. It ranks #6 among 7 general clinical decision support tools under this rubric. The score is an editorial assessment, not an aggregate of user reviews or a clinical performance benchmark.
Source: Clinical AI Report, May 2026
Our Assessment
In our 2026 evaluation, UpToDate (ranked #3, 3.6 stars) outperforms Epocrates (ranked #6, 3.2 stars) in overall physician satisfaction and editorial scoring. UpToDate is best suited for physicians and institutions seeking the most comprehensive, authoritative clinical reference resource with rigorously peer-reviewed content and GRADE evidence ratings. Meanwhile, Epocrates is a stronger choice for physicians and residents seeking a fast, reliable, mobile-first drug reference tool with a strong free tier — especially for interaction checks and dosing at the point of care. Both tools serve important but distinct roles in clinical care workflows, and physicians should choose based on their specific workflow requirements and institutional needs.